There is no word yet on when the IPO will happen. According to Voyager, it is still working out "the number of shares to be ...

Nasdaq president Nelson Griggs discusses the decline of companies going public and when the incentive for initial public ...

When US tech stocks were crushed by the emergence of DeepSeek this week, already-cautious investors found one more reason to ...

Investors in defense stocks seem a bit nervous at the prospect, and defense stocks have been generally down over the past three months. Where to invest $1,000 right now? Our analyst team just revealed ...

The Indian primary market remains robust amid secondary market volatility, with 29 companies listing in January, driven by ...

Nasdaq Inc. Chief Executive Officer Adena Friedman said she expects a strong environment for initial public offerings in the second quarter and balance of 2025 as investors gain confidence from ...

The US IPO market experienced a rebound in 2024, with proceeds and deal volume increasing as compared to the previous two ...

Discover new preferred stock and exchange-traded debt offerings in January with yields up to 9.125%. Click here to read what ...

Metsera, Inc MTSR IPO will take place January, 31 on the NASDAQ exchange under the ticker MTSR. The company is offering shares at an expected price between $15.00 and $17.00 per share with an insider ...

The IPO trend remains robust in 2025, driven by strong retail investor interest and a shift from FPIs to the primary market.

Maze Therapeutics ( NASDAQ: MAZE) shares were trading largely flat following a $140M initial public offering. Shares of the kidney disease drug developer opened at $16 per share after being priced at ...